Insider Transactions in Q2 2021 at Ironwood Pharmaceuticals Inc (IRWD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+1.08%
|
-
|
|
Jun 15
2021
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
1,565
+2.09%
|
-
|
|
Jun 15
2021
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
1,229
+1.91%
|
-
|
|
Jun 14
2021
|
Mark G Currie |
SELL
Open market or private sale
|
Direct |
23,571
-3.97%
|
$259,281
$11.59 P/Share
|
|
Jun 07
2021
|
Thomas A Mccourt Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
104,690
+13.49%
|
-
|
|
Jun 02
2021
|
Mark G Currie |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+3.69%
|
-
|
|
Jun 02
2021
|
Andrew Dreyfus |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+14.72%
|
-
|
|
Jun 02
2021
|
Jon R Duane |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+24.49%
|
-
|
|
Jun 02
2021
|
Marla L Kessler |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+24.49%
|
-
|
|
Jun 02
2021
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+13.3%
|
-
|
|
Jun 02
2021
|
Catherine Moukheibir |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+24.08%
|
-
|
|
Jun 02
2021
|
Lawrence S Olanoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+19.94%
|
-
|
|
Jun 02
2021
|
Edward P Owens Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+8.61%
|
-
|
|
Jun 02
2021
|
Jay Shepard |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+28.08%
|
-
|
|
Jun 02
2021
|
Alexander J Denner |
BUY
Grant, award, or other acquisition
|
Direct |
22,766
+26.91%
|
-
|
|
May 24
2021
|
Thomas A Mccourt Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,716
-0.3%
|
$20,592
$12.25 P/Share
|
|
May 24
2021
|
Jason Rickard SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
516
-0.14%
|
$6,192
$12.25 P/Share
|
|
May 24
2021
|
Michael Shetzline CMO,SVP,Head-Res&Drug |
SELL
Open market or private sale
|
Direct |
2,077
-1.04%
|
$24,924
$12.25 P/Share
|
|
Apr 20
2021
|
Julie Mc Hugh |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.95%
|
-
|